Bailard’s Ingevity NGVT Stock Holding History

Bailard’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-44,258	Closed	-$3.26M	–	530
2018 Q1	$3.26M	Sell	44,258 -48	-0.1%	-$3.59K	0.21%	121
2017 Q4	$3.12M	Sell	44,306 -130	-0.3%	-$9.38K	0.2%	122
2017 Q3	$2.78M	Buy	+44,436	New	+$2.63M	0.21%	117

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIC

Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Bailard's NGVT Position: Q2 2018 in Review

Bailard sold out of Ingevity (NGVT) in Q2 2018, closing a stake of 44,258 shares — an estimated $3.26M sold.

Bailard first reported a position in NGVT in Q3 2017 and held it in 3 quarters. The position peaked at $3.26M in Q1 2018. 309 funds tracked by Wall St. Rank hold NGVT as of Q2 2018.

Bailard reported no remaining Ingevity position as of Q2 2018 after selling out during the quarter.
Bailard sold 44,258 Ingevity shares in Q2 2018, an estimated $3.26M.
Bailard first reported a position in Ingevity in Q3 2017 and held it in 3 quarters.
Bailard's Ingevity position peaked at $3.26M in Q1 2018.
309 funds tracked by Wall St. Rank held Ingevity as of Q2 2018.

Based on Bailard's 13F filing for Q2 2018, filed 8 Aug 2018.